Nashville city leaders, local clergy, advocates for gun reform and Antioch High School teacher respond to school shooting at ...

President Donald Trump has issued a “full and unconditional pardon” to Washington, DC, police lieutenant Andrew Zabavsky and ...

U.S. Marshals are offering a $5,000 reward in addition to a $30,000 reward from Stockton Crime Stoppers for information that ...

Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...

Around 100 community members and first responders gathered at the Calcutta Volunteer Fire Department in St. Clair Township, Ohio, to hold a vigil for Detective Dakota Wetzel and 4-year-old Rosalie ...

President Donald Trump has signed an executive order saying the United States will designate drug cartels as foreign ...

Rosalie Martin was in a nearby dentist's office when a stray bullet came through the window and hit her. The suspect accused of firing on police was also killed.

Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.

Two years ago, seven people were killed in Half Moon Bay when a disgruntled employee opened fire at two local mushroom farms. On Thursday, the city and its ...

A vigil took place Thursday night at the Calcutta Fire Department to honor the life of 4-year-old Rosalie Martin and to show ...

Thursday night in London, around 50 people gathered to remember Doug Harless, the man who authorities say was shot and killed by police on Dec. 23.

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially representing a new avenue for treating Alzheimer’s disease.